Ingredient
Cimicifuga Dahurica Root Extract
Cimicifuga Dahurica Root Extract is flagged for pregnancy, breastfeeding, trying to conceive and PCOS. The concern behind the strongest flag is hormone disruptor and fetal development.
- Dahurian Bugbane Extract
- Sheng Ma Extract
- Cimicifuga dahuria
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 4 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 1 of 5
- Higher means more likely to sting or redden
Cimicifuga Dahurica Root Extract and pregnancy
Not Recommended
- Hormone disruptor
- Fetal development
Cimicifuga dahurica root extract comes from a plant closely related to black cohosh (Actaea racemosa), and like its cousin, it contains compounds with potential estrogenic and hormonal activity. The extract is used in cosmetics for antioxidant benefits. The primary concern during pregnancy is the plant's phytoestrogenic compounds. While oral black cohosh supplements are well-documented as potentially triggering uterine contractions and hormonal disruption, topical data for Cimicifuga dahurica specifically is limited. However, the American Pregnancy Association and many herbalists recommend avoiding all Actaea/Cimicifuga species during pregnancy due to their hormone-like effects and traditional use as labor-inducing agents. Even with lower absorption from topical products, the theoretical risks to hormonal balance and pregnancy maintenance warrant caution. Most obstetricians and midwives recommend avoiding black cohosh and related species during pregnancy. While regulatory bodies haven't issued specific bans on topical cosmetic use, the precautionary principle suggests pregnant women choose products without this extract, especially given the availability of safer antioxidant alternatives.
Cimicifuga Dahurica Root Extract and breastfeeding
Caution Advised
- Passes into breast milk
- Interferes with hormones
Cimicifuga dahurica extract contains phytoestrogens and bioactive compounds related to those in black cohosh. While topical absorption is lower than oral ingestion, the extract's hormonal activity raises theoretical concerns. The primary concern for breastfeeding is the potential transfer of phytoestrogenic compounds to breast milk and their possible effects on infant hormone exposure. While specific studies on topical Cimicifuga dahurica during lactation don't exist, herbalists and lactation consultants often recommend caution with black cohosh and related species due to their hormonal effects. Additionally, some Actaea species have been associated with milk supply changes in traditional medicine, though evidence is anecdotal. Given the uncertainty and theoretical hormonal risks, many healthcare providers suggest breastfeeding mothers avoid products with this extract or limit use to small areas. Safer antioxidant alternatives are widely available.
Cimicifuga Dahurica Root Extract and postpartum
Safe to Use
Cimicifuga dahurica extract provides antioxidant benefits and may help with skin inflammation. For postpartum women not breastfeeding, the primary pregnancy concerns no longer apply. While the extract contains phytoestrogens, topical use in cosmetics typically involves low concentrations and minimal systemic absorption. Postpartum women not breastfeeding can generally use this ingredient, though those with hormone-sensitive conditions or irregular cycles may prefer to wait until hormonal balance is restored.
Cimicifuga Dahurica Root Extract and trying to conceive
Caution Advised
- Hormone disruptor
- Fertility effects
Cimicifuga dahurica extract contains phytoestrogens and compounds with hormonal activity. For women trying to conceive, maintaining optimal hormonal balance is important. While there's no direct evidence that topical cosmetic use affects fertility, the plant's estrogenic properties and traditional use for menstrual regulation suggest potential hormone-modulating effects. Women trying to conceive may prefer to minimize exposure to hormone-active compounds, even topically. Many fertility specialists recommend avoiding black cohosh and related species during the conception period as a precautionary measure.
Cimicifuga Dahurica Root Extract and PCOS
Caution Advised
- Interferes with hormones
- Affects estrogen
Cimicifuga dahurica extract is an antioxidant derived from a plant with known phytoestrogenic properties. These plant compounds can interact with estrogen receptors in the body. For women with PCOS, the hormonal activity of this extract is a concern. PCOS involves complex hormonal imbalances, and introducing phytoestrogens could theoretically affect the delicate balance between estrogen, progesterone, and androgens. While topical absorption is limited, women with PCOS who are particularly sensitive to hormonal changes or taking medications for hormone regulation may want to exercise caution. There's no definitive evidence that topical use causes problems in PCOS, but given the condition's hormonal nature and the ingredient's estrogenic potential, many women with PCOS prefer to avoid it in favor of non-hormonal antioxidants.
Cimicifuga Dahurica Root Extract and general use
Safe to Use
Cimicifuga dahurica root extract is a botanical ingredient used in cosmetics for its antioxidant and anti-inflammatory properties. It comes from a plant related to black cohosh and has been used in traditional Chinese medicine. For the general public without hormonal concerns, this ingredient is generally well-tolerated in cosmetic products. The antioxidant benefits can help protect skin from environmental damage. While the plant contains phytoestrogens, topical application in typical cosmetic concentrations is unlikely to cause systemic effects in healthy adults. Rare cases of skin sensitivity may occur, as with any botanical extract. The ingredient is permitted in cosmetics by regulatory bodies, though it lacks extensive safety testing specific to topical cosmetic use. It's considered relatively safe for general use, with primary cautions reserved for hormone-sensitive populations.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Cimicifuga Dahurica Root Extract, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store